Chinese Clinical Oncology
• 综述与讲座 • Previous Articles Next Articles
YU Wantao, WANG Zhaoxia.
Received:
Revised:
Online:
Published:
Contact:
Abstract: Recent studies have shown that miR-100 can act as oncogene or tumor suppressor gene in different tumors. It not only plays an important role in the development and progression of a variety of tumor types(cervical cancer, prostate cancer, bladder cancer, lung cancer, etc), but also can resensitize tumor cell towards chemotherapeutic drugs. miR-100 is expected to become a new target for cancer treatment and a new molecular marker for prognostic predictors. In this review, we summarize the latest progresses, both domestic and overseas, in the roles of miR-100 in the tumor development.
YU Wantao, WANG Zhaoxia.. Research progress on miR-100 and tumor[J].Chinese Clinical Oncology, 2014, 19(8): 747-.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://manu65.magtech.com.cn/Jwk3_lczlxzz/EN/
http://manu65.magtech.com.cn/Jwk3_lczlxzz/EN/Y2014/V19/I8/747
Cited